Organism Function – Page 5

FDA Places Partial Clinical Hold on Zentalis’ Azenosertib Cancer Studies Following Two Sepsis Deaths

12 months ago talkbio0Tagged cancer studies, Cessation of life, Clinical Trials, Inhibitor, Partial, patient safety, Septicemia, Study on Hold, United States Food and Drug Administration, WEE1 gene, Zentalis

Zentalis Pharmaceuticals, azenosertib, FDA, partial clinical hold, cancer studies, sepsis deaths, WEE1 inhibitor, clinical trials, patient safety

Aerovate Therapeutics’ Shares Plummet 93.3% After Disappointing IMPAHCT Study Results for AV-101 in Pulmonary Arterial Hypertension

12 months ago talkbio0Tagged 4-aminohippuric acid, Aerovate, AV-101, Biotech Stocks, Clinical Trials, Drug Formulation Process, imatinib, IMPAHCT, Inspiration function, Pulmonary arterial hypertension

Aerovate Therapeutics, AV-101, IMPAHCT Study, Pulmonary Arterial Hypertension, PAH, Imatinib, Inhaled Formulation, Biotech Stocks, Clinical Trials

Syntis Bio Launches Revolutionary Oral Therapy to Mimic Weight-Loss Surgery

12 months ago talkbio0Tagged Bio, Diabetes, Digestion, drug absorption, gastric bypass surgery, Intestines, Metabolic Control, Obesity, Oral Therapy, SYNT-101, Syntis, weight-loss surgery

Syntis Bio, weight-loss surgery, oral therapy, obesity, diabetes, rare diseases, SYNT-101, gastric bypass surgery, small intestine, metabolic control, digestion, drug absorption.

Senate Fails to Pass Bill Codifying Access to Contraception Amid Republican Opposition

1 year ago talkbio0Tagged Birth, Contraceptive methods, Control Groups, Gegenhalten, Republican, rights, Senate, Voting

Contraception, Senate Vote, Republican Opposition, Reproductive Rights, Birth Control

Repare Backer Amplitude Ventures Launches $192M Biotech Fund for Development and Growth

1 year ago talkbio0Tagged Amplitude, biotech fund, Biotechnology, development aspects, Growth, Investments, Repare, Ventures

Amplitude Ventures, biotech fund, Repare Therapeutics, development, growth, investment, biotechnology

Ozempic Reduces Mortality Risk by 20% in Diabetes Patients with Chronic Kidney Disease

1 year ago1 year ago talkbio0Tagged Cardiovascular system, Cessation of life, Chronic Kidney Diseases, Diabetes, Failure (biologic function), Kidney, Mortality Vital Statistics, Nordisk, Obesity, semaglutide, Wegovy

** Ozempic, Novo Nordisk, diabetes, chronic kidney disease, mortality risk, cardiovascular deaths, kidney failure, semaglutide, Wegovy, obesity treatment

J&J Adjusts Dosing Strategy for Actinium Prostate Cancer Drug Following Early Study Setbacks

1 year ago talkbio0Tagged Actinium, Cancer Therapeutic Procedure, Cessation of life, Clinical Trials, dosing, Drug Development, Flexible, J&J, Johnson & Johnson, Malignant neoplasm of prostate

J&J, Johnson & Johnson, actinium prostate cancer drug, capped dosing, flexible dosing, patient deaths, early study, clinical trial, cancer treatment, drug development.